Alignment Healthcare Inc (NAS:ALHC)
$ 14.84 -3.76 (-20.2%) Market Cap: 3.08 Bil Enterprise Value: 2.71 Bil PE Ratio: 78.11 PB Ratio: 11.59 GF Score: 79/100

Q4 2025 Alignment Healthcare Inc Earnings Call Transcript

Feb 26, 2026 / 10:00PM GMT
Release Date Price: $20.42 (+1.44%)

Key Points

Positve
  • Alignment Healthcare Inc (ALHC) reported a 25% year-over-year growth in health plan membership, reaching 236,300 members.
  • Total revenue for the fourth quarter of 2025 was $1 billion, representing a 44% increase year over year.
  • The company exceeded the high end of guidance across profitability metrics, with adjusted EBITDA of $11 million surpassing the guidance range.
  • ALHC achieved a significant milestone by transforming from breakeven in 2024 to delivering an adjusted EBITDA of $110 million in 2025.
  • The company was recognized by Fortune magazine as one of the world's most admired companies, highlighting its commitment to seniors.
Negative
  • The industry is facing a relatively flat rate environment for 2027, which could impact future growth and profitability.
  • The final phase-in of the B28 risk model and changes in the Part D program present ongoing challenges.
  • New member mix, particularly with dual eligible and CSNip eligible members, may result in higher MBRs in the first year.
  • The company is navigating significant disruption in the Medicare Advantage industry, which could affect future performance.
  • There is uncertainty regarding potential incremental changes from CMS's RFI, which could impact the company's operations.
Operator

Good afternoon and welcome to Alignment Healthcare 4th quarter 2025 earnings conference call and webcast.

All participants will be in a listen-only mode.

After instructions after today's presentation, there will be an opportunity to ask questions.

Operator instructions, please note that this event is being recorded.

Leading today's call is John Cao, founder and CEO.

And Jim Head, Chief Financial Officer.

Before we begin, we would like to remind you that certain statements made during this call will be forward-looking statements as defined by the Private Securities Litigation Reform Act.

These forward-looking statements are subject to various risks and uncertainties and reflect our current expectations based on our beliefs, assumptions, and information currently available to us.

Descriptions of some of the factors that could cause actual results to differ materially from these forward-looking statements are discussed in more detail in our filings with the SEC, including the risk factors, sections of our annual report on Form 10k

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot